Cargando…
The kinase inhibitor SI113 induces autophagy and synergizes with quinacrine in hindering the growth of human glioblastoma multiforme cells
BACKGROUND: Glioblastoma multiforme (GBM), due to its location, aggressiveness, heterogeneity and infiltrative growth, is characterized by an exceptionally dismal clinical outcome. The small molecule SI113, recently identified as a SGK1 inhibitor, has proven to be effective in restraining GBM growth...
Autores principales: | Matteoni, Silvia, Abbruzzese, Claudia, Matarrese, Paola, De Luca, Gabriele, Mileo, Anna M., Miccadei, Stefania, Schenone, Silvia, Musumeci, Francesca, Haas, Tobias L., Sette, Giovanni, Carapella, Carmine M., Amato, Rosario, Perrotti, Nicola, Signore, Michele, Paggi, Marco G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6525441/ https://www.ncbi.nlm.nih.gov/pubmed/31101126 http://dx.doi.org/10.1186/s13046-019-1212-1 |
Ejemplares similares
-
The small molecule SI113 synergizes with mitotic spindle poisons in arresting the growth of human glioblastoma multiforme
por: Abbruzzese, Claudia, et al.
Publicado: (2017) -
Drug repurposing for the treatment of glioblastoma multiforme
por: Abbruzzese, Claudia, et al.
Publicado: (2017) -
Molecular Biology in Glioblastoma Multiforme Treatment
por: Abbruzzese, Claudia, et al.
Publicado: (2022) -
SI113, a SGK1 inhibitor, potentiates the effects of radiotherapy, modulates the response to oxidative stress and induces cytotoxic autophagy in human glioblastoma multiforme cells
por: Talarico, Cristina, et al.
Publicado: (2016) -
Repurposing chlorpromazine in the treatment of glioblastoma multiforme: analysis of literature and forthcoming steps
por: Abbruzzese, Claudia, et al.
Publicado: (2020)